Çѱ¹¹ÙÀÌ¿ÀÇùȸ´Â ±¹³» ¹ÙÀÌ¿À ±â¾÷ÀÇ ÇØ¿ÜÇù·Â ¹× ±Û·Î¹ú ³×Æ®¿öÅ© ±¸ÃàÀ» Áö¿øÇÏ°íÀÚ
µ¶ÀÏ ¹ÙÀÌ¿¤ÀÇ ¿ÀÇ À̳뺣À̼ǿ¡ Âü¿©ÇÒ ±¹³» ¹ÙÀÌ¿À ½ºÅ¸Æ®¾÷À» ¸ðÁýÇÏ°íÀÚ ÇÕ´Ï´Ù.
1. Âü°¡´ë»ó : ±Û·Î¹ú ¹ÙÀÌ¿À·Á¦¾à ±â¾÷°ú °³¹æÇü Çù¾÷À» Èñ¸ÁÇϴ â¾÷ ÈÄ 7³â ÀÌÇÏ ¹ÙÀÌ¿À ½ºÅ¸Æ®¾÷(2014.1.1 ÀÌÈÄ Ã¢¾÷)
2. Áö¿ø¹æ¹ý : ÷ºÎÀÇ Âü°¡½Åû¼, ¿µ¹® ¹ßÇ¥ÀÚ·á(Pitch Deck) ¹× °³ÀÎÁ¤º¸ µ¿ÀǼ À̸ÞÀÏ Á¢¼ö
3. Æò°¡ÀýÂ÷ : Á¦Ãâ ¼·ù ±â¹Ý ¼¸éÆò°¡(°³º° Å뺸 ¿¹Á¤)
4. ÇâÈÄÀÏÁ¤ : Âü°¡±â¾÷ ¼±Á¤(3¿ù 3ÁÖ), 1:1 ¹ÌÆÃ(3¿ù 4ÁÖ~4¿ù 1ÁÖ)
5. ¸ðÁý±â°£ : 2021. 2. 25(¸ñ) ~ 3. 17(¼ö)
6. Èñ¸ÁÇù·ÂºÐ¾ß
· Safety switches (mechanisms to shut down/eliminate cells if something goes wrong,
e.g. transformation, uncontrolled proliferation)
· Novel gene editing reagents
· Delivery technologies (mostly non-AAV for gene therapy)
· Allogeneic editing/hypo-immunogenic modification
· Scientific software development companies who can develop/program custom-made modern scientific software
· RNA-targeting Small Molecules
· Exploring/understanding new mechanisms of aging with the goal of identifying new therapeutics
for regenerative medicine and age-related indications (e.g. cardiovascular and oncology)
· Proteomics
· Metabolomics
· Chemical Probe Design and Imaging
· Protein Degradation
· lncRNA, miRNA, piRNA Biology
· RNA Target Identification and Validation Technologies
· RNA Structure Probing
7. ¹®ÀÇ : Çѱ¹¹ÙÀÌ¿ÀÇùȸ ¹Ì·¡¼ºÀåºÎ¹® (031-628-0042, ehchoi@koreabio.org)